Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1Suspended 1Not yet recruiting 1Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Gynecologic 1

Conditions

Leukemia, Myeloid, Acute 141Precursor Cell Lymphoblastic Leukemia-Lymphoma 65Hematologic Neoplasms 65Leukemia 36Leukemia, Lymphocytic, Chronic, B-Cell 34Myelodysplastic Syndromes 24Recurrence 23Lymphoma 23Leukemia, Myelogenous, Chronic, BCR-ABL Positive 15Neoplasms 14Multiple Myeloma 9Motor Activity 9Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 8Neoplasm, Residual 8Lymphoma, Non-Hodgkin 8Lymphoma, Follicular 8Lymphoma, B-Cell 8Leukemia, B-Cell 8Lymphoma, Mantle-Cell 6Burkitt Lymphoma 6Myeloproliferative Disorders 5Lymphoma, Large B-Cell, Diffuse 5Lymphoma, B-Cell, Marginal Zone 5Leukemia, Plasma Cell 5Leukemia, Myeloid, Chronic-Phase 5Febrile Neutropenia 5Waldenstrom Macroglobulinemia 4Pain 4Neoplasm Metastasis 4Leukemia, Myelomonocytic, Chronic 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Hereditary Sensory and Autonomic Neuropathies × Other hematologic neoplasm × Clear all
NCT07137637 2025-08-22

HPB-092 for the Treatment of Relapsed and Refractory Acute Myeloid Leukemia

Hangzhou Polymed Biopharmaceuticals, Inc.

Phase 1 Not yet recruiting
60 enrolled
Other hematologic neoplasm

Hereditary Sensory and Autonomic Neuropathies, Recurrence, Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡